Healthcare provider profile · identity verified

Farooq Mohammed, MD

Internal Medicine · CHICAGO, IL · NPI 1477730612

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	921	277
Atorvastatin Calcium	Atorvastatin Calcium	762	226
Losartan Potassium	Losartan Potassium	437	115
Metoprolol Succinate	Metoprolol Succinate	425	116
Rosuvastatin Calcium	Rosuvastatin Calcium	352	121
Metformin Hcl	Metformin Hcl	329	89
Hydrochlorothiazide	Hydrochlorothiazide	320	95
Furosemide	Furosemide	240	57
Gabapentin	Gabapentin	228	57
Omeprazole	Omeprazole	221	70
Lisinopril	Lisinopril	216	62
Albuterol Sulfate Hfa	Albuterol Sulfate	212	71
Tamsulosin Hcl	Tamsulosin Hcl	199	55
Hydralazine Hcl	Hydralazine Hcl	195	56
Baclofen	Baclofen	194	81
Carvedilol	Carvedilol	194	58
Metformin Hcl Er	Metformin Hcl	182	55
Eliquis	Apixaban	149	38
Levothyroxine Sodium	Levothyroxine Sodium	148	41
Potassium Chloride	Potassium Chloride	141	40
Pantoprazole Sodium	Pantoprazole Sodium	140	49
Olmesartan Medoxomil	Olmesartan Medoxomil	139	37
Montelukast Sodium	Montelukast Sodium	137	29
Nifedipine Er	Nifedipine	136	37
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	135	45
Metoprolol Tartrate	Metoprolol Tartrate	134	31
Allopurinol	Allopurinol	116	38
Spironolactone	Spironolactone	112	35
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	109	27
Famotidine	Famotidine	109	40
Tramadol Hcl	Tramadol Hcl	108	29
Acetaminophen-Codeine	Acetaminophen With Codeine	107	35
Ozempic	Semaglutide	103	24
Pravastatin Sodium	Pravastatin Sodium	99	30
Meloxicam	Meloxicam	91	35
Jardiance	Empagliflozin	82	20
Simvastatin	Simvastatin	81	27
Fluticasone Propionate	Fluticasone Propionate	77	32
Glipizide Er	Glipizide	77	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	22
Triamcinolone Acetonide	Triamcinolone Acetonide	73	27
Alendronate Sodium	Alendronate Sodium	68	22
Ezetimibe	Ezetimibe	63	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	55	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	16
Symbicort	Budesonide/Formoterol Fumarate	54	12
Mirtazapine	Mirtazapine	53	21
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	51	26
Enalapril Maleate	Enalapril Maleate	49	15
Trazodone Hcl	Trazodone Hcl	47	13
Zolpidem Tartrate	Zolpidem Tartrate	46	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	43	13
Duloxetine Hcl	Duloxetine Hcl	42	19
Irbesartan	Irbesartan	42	14
Entresto	Sacubitril/Valsartan	41	suppressed
Januvia	Sitagliptin Phosphate	39	12
Trulicity	Dulaglutide	38	suppressed
Clonidine Hcl	Clonidine Hcl	37	suppressed
Alprazolam	Alprazolam	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	11
Benazepril Hcl	Benazepril Hcl	34	suppressed
Colchicine	Colchicine	34	13
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Farxiga	Dapagliflozin Propanediol	33	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Finasteride	Finasteride	31	suppressed
Glipizide	Glipizide	31	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	31	14
Prednisone	Prednisone	30	suppressed
Glimepiride	Glimepiride	29	suppressed
Lovastatin	Lovastatin	27	suppressed
Sertraline Hcl	Sertraline Hcl	27	suppressed
Atenolol	Atenolol	26	suppressed
Felodipine Er	Felodipine	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	13
Donepezil Hcl	Donepezil Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Clotrimazole	Clotrimazole	20	12
Rybelsus	Semaglutide	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	20	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Naloxone Hcl	Naloxone Hcl	18	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Azithromycin	Azithromycin	14	12
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Single Use Swab	Alcohol Antiseptic Pads	13	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Mitigare	Colchicine	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Nystop	Nystatin	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error